The Role of BTK in TLR Signaling von Marron, T.U

Volltext

1051P Intratumoral injection of LTX-315 in combination with pembrolizumab in patients with advanced melanoma refractory to prior PD-1/PD-L1 therapy: Interim results from the ATLAS-... von Dalle, S., Marron, T.U., Robert, C., Aljabri, B., Nyakas, M.S., Bruins Slot, K., Sundvold, V., Rekdal, Ø., Sveinbjornsson, B., Currie, G.

Volltext

EP12.01-10 Predictors of Poor Outcomes Among Patients Receiving 1st-Line Osimertinib for Advanced EGFR Mutated Non-Small Cell Lung Cancer von Desland, F., Fitzgerald, B.G., Sheppard, R.S., Van Hyfte, G., Shimkus, M., Rohs, N.C., Veluswamy, R., Rolfo, C.D., Marron, T.U., Smith, C.B., Gomez, J.E., Doroshow, D.B.

Volltext

1025MO Preliminary safety, pharmacokinetics and immunomodulatory activity of RBS2418, an oral ENPP1 inhibitor, alone and in combination with pembrolizumab in patients with solid tu... von Marron, T.U., Misleh, J.G., C. chen, Wainberg, Z.A., Powderly, J., Boccia, R., Gordon, M., Segar, J., Csiki, I., Schanzer, J.M., O'Toole, L., Huang, N., Seppa, J., Glenn, J., Klumpp, K., Spira, A.I.

Volltext

Lung cancer research and treatment: global perspectives and strategic calls to action von Meyer, M.-L., Peters, S., Mok, T.S., Lam, S., Yang, P.-C., Aggarwal, C., Brahmer, J., Dziadziuszko, R., Felip, E., Ferris, A., Forde, P.M., Gray, J., Gros, L., Halmos, B., Herbst, R., Jänne, P.A., Johnson, B.E., Kelly, K., Leighl, N.B., Liu, S., Lowy, I., Marron, T.U., Paz-Ares, L., Rizvi, N., Rudin, C.M., Shum, E., Stahel, R., Trunova, N., Bunn, P.A., Hirsch, F.R.

Volltext

Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma von Manfredi, G.F., Fulgenzi, C.A.M., D'Alessio, A., Celsa, C., Stefanini, B., Cheon, J., Ang, C., Marron, T.U., Saeed, A., Wietharn, B., Pressiani, T., Pinter, M., Scheiner, B., Huang, Yi-Hsiang, Phen, S., Naqash, A. Rafeh, Piscaglia, F., Lin, R. Po-Ting, -yen Lin, C., Dalbeni, A., Vivaldi, C., Masi, G., Thimme, R., Vogel, A., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Galle, P.R., Kudo, M., Rimassa, L., Singal, A., Sharma, R., Cortellini, A., Jae Chon, H., Burlone, M., Pirisi, M., Pinato, D.J.

Volltext

IA13 Targeting Myeloid Cells that Define the Tumor Immune Microenvironment in NSCLC von Marron, T.U., Leader, A., Lavin, Y., Maier, B., Casanova-Acebes, M., Wolf, A., Flores, R., Beasley, M., Rahman, A., Kenigsberg, E., Merad, M.

Volltext

P2.12-05 Cancer and Atopy: Parallel Drivers? IL-4 Blockade Synergizes with PD-L1 Blockade to Reverse Type-2Mediated Immunosuppression von Marron, T.U., Maier, B., LaMarche, N.M., Hegde, S., Belabed, M., Mattiuz, R., Hennequin, C., LeBerichel, J., Park, M.D., Hall, N., Ogrady, D., Fitzgerald, B., Gomez, J.E., Doroshow, D.B., Veluswamy, R., Rolfo, C., Smith, C.B., Rohs, N., Yankelevitz, D., Chaddha, U., Harkin, T., Beasley, M.B., Hirsch, F.R., Merad, M.

Volltext

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours von Celsa, C., Cabibbo, G., Fulgenzi, C. AM, Scheiner, B., d'Alessio, A., Manfredi, G. F, Nishida, N., Ang, C., Marron, T.U., Saeed, A., Wietharn, B., Pinter, M., Cheon, J., Huang, Yi-Hsiang, Lee, Pei-Chang, Phen, S., Gampa, A., Pillai, A., Vivaldi, C., Salani, F., Masi, G., Roehlen, N., Thimme, R., Vogel, A., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Galle, P.R., Kudo, M., Rimassa, L., Singal, A.G., Tomb, P. El, Ulahannan, S., Parisi, A., Chon, H. Jae, Hsu, Wei-Fan, Stefanini, B., Verzoni, E., Giusti, R., Veccia, A., Catino, A., Aprile, G., Guglielmini, P.F., Di Napoli, M., Ermacora, P., Antonuzzo, L., Rossi, E., Verderame, F., Zustovich, F., Ficorella, C., Di Pietro, F.R., Battelli, N., Negrini, G., Grossi, F., Bordonaro, R., Pipitone, S., Banzi, M., Ricciardi, S., Laera, L., Russo, A., De Giorgi, U., Cavanna, L., Sorarù, M., Montesarchio, V., Bordi, P., Brunetti, L., Pinto, C., Bersanelli, M., Cortellini, A., Cammà, C., Pinato, D.J.

Volltext

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors von Perez, B., Aljumaily, R., Marron, T.U., Shafique, M.R., Burris, H., Iams, W.T., Chmura, S.J., Luke, J.J., Edenfield, W., Sohal, D., Liao, X., Boesler, C., Machl, A., Seebeck, J., Becker, A., Guenther, B., Rodriguez-Gutierrez, A., Antonia, S.J.

Volltext

LBA4 Low-dose stereotactic body radiotherapy prior to pre-operative cemiplimab for patients with resectable hepatocellular carcinoma von Marron, T.U., Hapanowicz, O., Lucas, N., Wu, K., Buckstein, M., Tabrizian, P., Taouli, B., Kim, E., Garcia-Reyes, K., Fiel, M.I., Ward, S., Cohen, N., Hiotis, S., Thanigaimani, P., Hao, Y., Lowy, I., Miller, E.A., Uldrick, T.S., Schwartz, M., Merad, M.

Volltext

170P Targeting myeloid cells in non-small cell lung cancer and hepatocellular carcinoma: A window-of-opportunity trial of nivolumab with BMS-813160 (CCR2/5i) or BMS-986253 (anti-IL... von Venturini, N.J., Hamon, P., Ward, S., Fiel, M.I., Beasley, M.B., Kim, E., Garcia-Reyes, K., Chaddha, U., Harkin, T., Gunasekaran, G., Tabrizian, P., Nicastri, D., Del Valle, D., Hennequin, C., Kim-Schulze, S., Gnjatic, S., Schwartz, M., Kaufman, A., Merad, M., Marron, T.U.

Volltext

111P Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours von Celsa, C., Cabibbo, G., Marron, T.U., Saeed, A., Pinter, M., Huang, Y-H., Pillai, A., Schoenlein, M., von Felden, J., Galle, P.R., Kudo, M., Rimassa, L., Singal, A., Chon, H., Hsu, W-F., Brunetti, L., Pinto, C., Bersanelli, M., Cortellini, A., Pinato, D.J.

Volltext

122P Casdozokitug (casdozo, SRF388), a first-in-class IL-27 targeting antibody, as monotherapy (monotx) or in combination with pembrolizumab (pembro) in treatment-refractory non-sm... von Marron, T.U., Naing, A., Mantia, C., Pennell, N., Kim, H.R., Villaruz, L., El-Khoueiry, A.B., Gerber, D.E., Qin, A., Kim, T-Y., Altan, M., Gandhi, L., Appleman, L.J., Yoon, S., Hill, J., Reichert, V., Masia, R., Harshman, L., Patnaik, A., Morgensztern, D.

Volltext

Supplementary Material for: Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma von P., Fessas, M., Naeem, M., Pinter, T.U., Marron, D., Szafron, L., Balcar, A., Saeed, T., Jun, S., Dharmapuri, A., Gampa, Y., Wang, U., Khan, M., Muzaffar, M., Navaid, P.-C., Lee, A., Bulumulle, B., Yu, S., Paul, N., Nimkar, D., Bettinger, H., Hildebrand, Y.I., Abugabal, T., Pressiani, N., Personeni, N., Nishida, M., Kudo, A., Kaseb, Y.-H., Huang, C., Ang, A., Pillai, L., Rimassa, A.R., Naqash, E., Sharon, A., Cortellini, D.J., Pinato

Volltext bestellen

Direct Volumetric Determination of Organic Sulfonate Content of Synthetic Detergents von Marron, T.U, Schifferli, Joseph

Volltext